627
Participants
Start Date
November 30, 2000
Primary Completion Date
August 31, 2002
Study Completion Date
August 31, 2002
Levalbuterol 1.25 mg
"levalbuterol 1.25 mg Period I: administered every 20 minutes for the first 3 doses, and then every 40 minutes for the next 3 doses; then as clinically indicated.~Period II: TID for 3 days (same time of day), then PRN to TID for 7 days"
Racemic Albuterol Sulfate
"Racemic Albuterol 2.5 mg Period I: every 20 min for the first 3 doses, then every 40 min for the next 3 doses, then as clinically indicated.~Period II: TID for 3 days then PRN to TID for 7 days"
Hoover
Montgomery
Encinitas
Fresno
Oakland
Torrance
Colorado Springs
Gainesville
Jacksonville
Tampa
Chicago
Metairie
Ann Arbor
Detroit
Kansas City
St Louis
Red Bank
Brooklyn
New Hyde Park
Syracuse
Rocky Mount
Akron
Cleveland
Lake Oswego
Medford
Philadelphia
Houston
Salt Lake City
Sumitomo Pharma America, Inc.
INDUSTRY